RecruitingNot ApplicableNCT05901558

Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD

Strategies for Toddler ASD With Remote-therapy (STAR) Model for Early ASD Toddlers: a Randomized Trial


Sponsor

Children's Hospital of Fudan University

Enrollment

110 participants

Start Date

Jun 15, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The project aims to develop and implement the Strategies for Toddler Autism spectrum disorder(ASD) with Remote-therapy (STAR) model for early toddlers with ASD in local community sites in Shanghai. It's a randomized control trial lasting 3 years. The children will be divided into 2 groups, one for STAR intervention group and the other for community intervention group. The STAR intervention group will be performed STAR other than community intervention.


Eligibility

Min Age: 16 MonthsMax Age: 30 Months

Inclusion Criteria2

  • Children screened as positive for ASD.
  • Two-tiered screening process combing Level 1(The Modified Checklist for Autism in Toddlers-Revised/Follow-Up , M-CHAT-R/F) and Level 2 (The Screening Tool for Autism in Toddlers and Young Children, STAT)

Exclusion Criteria4

  • Other neurologic or degenerative diseases;
  • Severe hearing or visual impairment;
  • Genetic anomaly which may affect impact on intervention;
  • Not available for regular intervention and follow-up.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALStrategies for Toddler ASD with Remote-therapy (STAR)

The intervention strategies in STAR model are designed under the Naturalistic Developmental Behavioral Intervention (NDBI) framework which are implemented in natural settings targeting at improving social and communicational capabilities

BEHAVIORALCommunity intervention

Regular community intervention


Locations(1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05901558


Related Trials